, , 1982.
, , 1989.
, , 1996.
, , 1996.
, , 1996.
, , 1997.
, , 2005.
, , 2007.
, , 2009.
, , 2011.
Blood biomarkers in stroke: research and clinical practice, Int J Stroke, vol.7, pp.435-439, 2012. ,
Blood markers for the prognosis of ischemic stroke: a systematic review, Stroke, vol.40, pp.380-389, 2009. ,
Blood glutathione S-transferase-? as a time indicator of stroke onset, PLoS One, vol.7, p.43830, 2012. ,
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study, Lancet Neurol, vol.10, pp.978-986, 2011. ,
Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, vol.44, pp.870-947, 2013. ,
Brain extracellular fluid protein changes in acute stroke patients, J Proteome Res, vol.10, pp.1043-1051, 2011. ,
Wake-up stroke and stroke of unknown onset : a critical review, Front Neurol, vol.5, p.153, 2014. ,
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility, Neurology, vol.56, pp.1015-1020, 2001. ,
Peroxiredoxins as biomarkers of oxidative stress, Biochim Biophys Acta, vol.1840, pp.906-912, 2014. ,
Glutathione peroxidase protects against peroxynitrite-mediated oxidations. A new function for selenoproteins as peroxynitrite reductase, J Biol Chem, vol.272, pp.27812-27817, 1997. ,
Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress ,
, Free Radic Biol Med, vol.17, pp.235-248, 1994.
Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury, J Cereb Blood Flow Metab, vol.20, pp.1467-1473, 2000. ,
Icariin inhibits hydrogen peroxide-mediated cytotoxicity by up-regulating sirtuin type 1-dependent catalase and peroxiredoxin, Basic Clin Pharmacol Toxicol, vol.107, pp.899-905, 2010. ,
Glutathione-S-transferase family of enzymes, Mutat Res, vol.482, pp.21-26, 2001. ,
Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification, Drug Metab Rev, vol.43, pp.179-193, 2011. ,
Protective effect of glutathione against lipopolysaccharide-induced inflammation and mortality in rats, Inflamm Res, vol.55, pp.504-510, 2006. ,
Recombinant protein glutathione S-transferases P1 attenuates inflammation in mice, Mol Immunol, vol.46, pp.848-857, 2009. ,
Peroxiredoxin 1 and its role in cell signaling, Cell Cycle, vol.8, pp.4072-4078, 2009. ,
Nitrosative stress induces peroxiredoxin 1 ubiquitination during ischemic insult via E6AP activation in endothelial cells both in vitro and in vivo, Antioxid Redox Signal, vol.21, pp.1-16, 2014. ,
, Peroxiredoxin, vol.2
, polymerase 1-and p53-dependent prodeath pathways after ischemic injury, Stroke, vol.44, pp.1124-1134, 2013.
Protective effects of peroxiredoxin-1 at the injured blood-brain barrier, Free Radic Biol Med, vol.45, pp.256-264, 2008. ,
Peroxiredoxin sets the brain on fire after stroke, Nat Med, vol.18, pp.858-859, 2012. ,
Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain, Nat Med, vol.18, pp.911-917, 2012. ,
S100B inhibition reduces behavioral and pathologic changes in experimental traumatic brain injury, J Cereb Blood Flow Metab, vol.35, pp.2010-2020, 2015. ,
E-selectin and vascular cell adhesion molecule-1 as biomarkers of 3-month outcome in cerebrovascular diseases, J Inflamm (Lond), vol.12, p.61, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01812488
Development of a colloidal gold-based lateral flow dipstick immunoassay for rapid qualitative and semi-quantitative analysis of artesunate and dihydroartemisinin, Malar J, vol.13, p.127, 2014. ,
,
Wake-up stroke and stroke of unknown onset : a critical review, Front Neurol, vol.5, p.153, 2014. ,
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility, Neurology, vol.56, pp.1015-1020, 2001. ,
, Tissue plasminogen activator for acute ischemic stroke. The National Institute of
, Neurological Disorders and Stroke rt-PA Stroke Study Group (NINDS), N Engl J Med, vol.333, pp.1581-1588, 1995.
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke, N Engl J Med, vol.359, pp.1317-1346, 2008. ,
A randomized trial of intraarterial treatment for acute ischemic stroke, N Engl J Med, vol.372, pp.11-20, 2015. ,
,
, Endovascular therapy for ischemic stroke with perfusion-imaging selection, N Engl J Med, vol.372, pp.1009-1027, 2015.
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials, Lancet, vol.375, pp.1695-703, 2010. ,
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (PRE-FLAIR): a multicenter observational study, Lancet Neurol, vol.10, pp.978-86, 2011. ,
Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the ,
, American Heart Association/American Stroke Association. Stroke, vol.44, pp.870-947, 2013.
Brain extracellular fluid protein changes in acute stroke patients, J Proteome Res, vol.10, pp.1043-1051, 2011. ,
Blood glutathione S-transferase-? as a time indicator of stroke onset, PLoS One, vol.7, p.43830, 2012. ,
Peroxiredoxins as biomarkers of oxidative stress ,
, Biochim Biophys Acta, vol.1840, pp.906-912, 2014.
Glutathione peroxidase protects against peroxynitrite-mediated oxidations. A new function for selenoproteins as peroxynitrite reductase, J Biol Chem, vol.272, pp.27812-27817, 1997. ,
Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress, Free Radic Biol Med, vol.17, pp.235-248, 1994. ,
Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury, J Cereb Blood Flow Metab, vol.20, pp.1467-1473, 2000. ,
Nitrosative stress induces peroxiredoxin 1 ,
, ubiquitination during ischemic insult via E6AP activation in endothelial cells both in vitro and in vivo, Antioxid Redox Signal, vol.21, pp.1-16, 2014.
Glutathione-S-transferase family of enzymes, Mutat Res, vol.482, pp.21-26, 2001. ,
Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification, Drug Metab Rev, vol.43, pp.179-193, 2011. ,
Protective effect of glutathione against lipopolysaccharide-induced inflammation and mortality in rats, Inflamm Res, vol.55, pp.504-510, 2006. ,
Recombinant protein glutathione S-transferases P1 attenuates inflammation in mice, Mol Immunol, vol.46, pp.848-857, 2009. ,
Peroxiredoxin 2 battles poly(ADP-ribose) polymerase 1and p53-dependent prodeath pathways after ischemic injury, Stroke, vol.44, pp.1124-1134, 2013. ,
Protective effects of peroxiredoxin-1 at the injured blood-brain barrier, Free Radic Biol Med, vol.45, pp.256-264, 2008. ,
Peroxiredoxin sets the brain on fire after stroke, Nat Med, vol.18, pp.858-859, 2012. ,
Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain, Nat Med, vol.18, pp.911-917, 2012. ,
A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP), Int J Stroke, vol.9, pp.829-865, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02045531
Blood biomarkers in stroke: research and clinical practice, Int J Stroke, vol.7, pp.435-439, 2012. ,
Blood markers for the prognosis of ischemic stroke: a systematic review, Stroke, vol.40, pp.380-389, 2009. ,
Accident vasculaire cérébral : prise en charge précoce (alerte, phase préhospitalière, phase hospitalière initiale, 2009. ,
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, doubleblind, parallel-group trial, Lancet, vol.377, pp.2013-2035, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00771537
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke, N Engl J Med, vol.359, pp.1238-51, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00627279